Genetic variations in the surface-binding domains of FH are associated with complement-mediated diseases, including age-related macular degeneration (AMD) and atypical hemolytic uremic syndrome (aHUS) (7, 8). This evidence concerns the gene FH and atypical hemolytic-uremic syndrome.